Abstract #301094

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2003 Program page



JSM 2003 Abstract #301094
Activity Number: 247
Type: Contributed
Date/Time: Tuesday, August 5, 2003 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract - #301094
Title: Evaluating Vaccine Safety Data Using Markov Chains
Author(s): Martin L. Lee*+ and Ken Zangwill and Joel Ward
Companies: University of California, Los Angeles and University of California, Los Angeles
Address: 3941 Eureka Dr., Studio City, CA, 91604-3110,
Keywords: vaccine safety ; Markov model ; chi-square tests
Abstract:

The analysis of vaccine safety data from population cohorts poses a number of issues. These include the rarity of adverse outcomes, nonexperimental data, and a complex correlation structure. Different approaches have been suggested including case-control and case-cohort designs. Others have used the "risk-interval" method, whereby vaccinees act as their own control and intervals before and/or after vaccination are compared with an at-risk period immediately postvaccination. We present an alternative approach which models the probability of events within these periods using a first-order Markov chain. This model is simple and provides chi-square tests of the relationship between vaccination and events of interest. It allows for determination of whether the Markov process is stationary and first order. We have applied these methods to a population-based dataset evaluating the relationship of gender to the incidence of adverse events following vaccination. We have demonstrated that our data fit this probability model and also determined associations that have been shown with more complex models using similar data. This model can be used for the evaluation of vaccine safety.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2003 program

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003